An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor, characterized by a high degree of intertumoral heterogeneity. However, a common feature of the GBM microenvironment is hypoxia, which can promote radio- and chemotherapy resistance, immunosuppression, angiogenesis,...
Main Authors: | Marta Calvo Tardón, Eliana Marinari, Denis Migliorini, Viviane Bes, Stoyan Tankov, Emily Charrier, Thomas A McKee, Valérie Dutoit, Pierre-Yves Dietrich, Erika Cosset, Paul R Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/9/9/264 |
Similar Items
-
Assessment of hypoxia and its dynamic evolution in glioblastoma via qBOLD MRI: a comparative study with metformin treatment
by: Dongdong Wang, et al.
Published: (2024-12-01) -
Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages
by: Stoyan Tankov, et al.
Published: (2024-02-01) -
GPT2 Is Induced by Hypoxia-Inducible Factor (HIF)-2 and Promotes Glioblastoma Growth
by: Bo Zhang, et al.
Published: (2022-08-01) -
Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines
by: Valerie J. Marallano, et al.
Published: (2024-03-01) -
Investigating Glioblastoma Response to Hypoxia
by: Agathe L. Chédeville, et al.
Published: (2020-08-01)